Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Article metrics

Correction to: Leukemia (2012) 26, 149–157; doi:10.1038/leu.2011.196

Since the publication of this paper, the authors have noticed that one of the author names in the appendix was incorrectly listed as Hareth Nari. It should be listed as follows:

Hareth Nahi, Karolinska University Hospital, Stockholm, Sweden.

The authors apologise for any inconvenience caused.

Author information

Additional information

The online version of the original article can be found at 10.1038/leu.2011.196

Rights and permissions

Reprints and Permissions

About this article

Further reading